Lv5
864 积分 2024-04-23 加入
Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa
2个月前
已完结
Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy
2个月前
已完结
HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B
2个月前
已完结
Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach
2个月前
已完结
A novel panel of blood markers to assess the degree of liver fibrosis†
2个月前
已完结
Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
2个月前
已完结
Predictive Value of Serum Albumin, Iron, Ferritin, and Hepcidin for Antiviral Efficacy of IFNα Treatment in Patients with Chronic Hepatitis B
2个月前
已关闭
Stopping nucleot(s)ide analogues in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels
2个月前
已完结
Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen–negative chronic hepatitis B
2个月前
已完结
Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
2个月前
已完结
皖公网安备34019202002308
